Global Academy

NCCN Global Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business


Free Online Program was held 16 September 2020.


NCCN Global Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business will provide pharmaceutical and biotechnology professionals the rare opportunity to view the global oncology space, its future and its current operational issues from the provider, payer, and patient advocate perspective. Participants will improve their working knowledge of key global business, policy, informational, and operational issues in oncology and will gather valuable insights to develop effective strategies for navigating worldwide cancer care issues. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in the global oncology environment and how to apply this knowledge to create mutually successful working relationships.

Professionals from marketing, sales, advocacy, medical affairs, clinical research, international programs, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Caitlin McAuley, Senior Global Business Development Specialist.



9:00 – 9:10 AMWelcome
9:10 – 10:50 AM

Module: Global Resources - Meet NCCN Guidelines Panel and Collaborative Experts


Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

Susan Citonje Msadabwe-Chikuni, MBChB, MMed
Clinical Oncology, Radiation Oncology
Cancer Diseases Hospital
Chair, NCCN Harmonized Guidelines™ for Sub-Saharan Africa for Antiemesis, Cervical Cancer, Gestational Trophoblastic Neoplasia Cancers, Hematopoietic Growth Factors, Uterine Neoplasms, Vulvar Cancer Panels

Abdul Rahman Jazieh, MD, MPH
Chairman, Department of Oncology,
King Abdulaziz Medical City in Riyadh
Saudi Arabia
NCCN Guideline for Non-Small Cell Lung Cancer
Collaborative International Expert
Director of the Coordinating Center, MENA

Wui-Jin Koh, MD
Chief Medical Officer
National Comprehensive Cancer Network

Sharon Spencer, MD
O'Neal Comprehensive Cancer Center at UAB
Vice-Chair, NCCN Head & Neck Cancer Panel

Andrew Zelenetz, MD, PhD
Medical Director, Quality Informatics, Department of Medicine, Attending Physician, Lymphoma Service, Division of Hematology/Oncology, Professor of Medicine, Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center
Chair, NCCN B-Cell Lymphoma Panel

10:50 – 11:00 AMClosing Remarks

*Curriculum subject to change.



Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.



Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.